Baijin Life Science Holdings Limited
1466.HKHKSEConsumer CyclicalDrug Manufacturers - Specialty & Generic
Latest quote
HK$0.89
−HK$0.01 · -1.11%
1466.HK company overview
Regular session · HKT · Market data may be delayed.
Company profile
Company websiteAffluent Partners Holdings Limited, an investment holding entity founded in 2014 and situated in Central, Hong Kong, conducts various operations. Its core business involves the full lifecycle of pearls and jewelry products, including their acquisition, processing, design, manufacturing, assembly, trading, and wholesale distribution. The company's activities are structured into two distinct divisions: the sale of pearl and jewelry items, and strategic investment alongside financial services. Additionally, it allocates capital to financial assets within the real estate sector. Affluent Partners operates internationally, with a footprint in Hong Kong, the United Kingdom, the United States, Japan, Europe, and mainland China. This enterprise was previously known as Man Sang Jewellery Holdings Limited, undergoing a name change to Affluent Partners Holdings Limited in February 2017.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Consumer Cyclical
- Headquarters
- HK
- CEO
- Sze Ming Cheung
- Listed since
- Oct 17, 2014
- Employees
- 84
Market position
Day range
Current HK$0.89
52-week range
Current HK$0.89
- Open
- HK$0.90
- Previous close
- HK$0.90
- Volume
- 137K
- 0.1× average
- Average volume
- 1.44M
- Average daily volume
- Market cap
- 829.71M HKD
- Beta
- -0.31
- Market reference 1
- 50-day average
- HK$0.9766
- -8.87% below average
- 200-day average
- HK$0.658
- +35.26% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 482.93M HKD
- P/E (TTM)
- -15.86×
- P/B (TTM)
- 4.32×
- P/S (TTM)
- 9.29×
- EV / EBITDA
- -12.59×
- Earnings yield
- -7.61%
- Free cash flow yield
- -4.53%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 7.46%
- Operating margin
- -37.74%
- Net margin
- -42.40%
- Return on equity
- -20.45%
- Return on assets
- -14.32%
- Return on invested capital
- -21.35%
Financial health
- Debt / equity
- 0.15×
- Current ratio
- 2.97×
Earnings
- Latest EPS result
- -0.01
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
1466.HK peers
Continue in GoAI
Research 1466.HKresearch.disclaimer